Scott David Priebe

Array ( [id] => 1415899 [patent_doc_number] => 06521602 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-18 [patent_title] => 'Anti-neoplastic compositions and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/516065 [patent_app_country] => US [patent_app_date] => 2000-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 30 [patent_no_of_words] => 29269 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/521/06521602.pdf [firstpage_image] =>[orig_patent_app_number] => 09516065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1549460 [patent_doc_number] => 06346409 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Tryptophenyl tRNA synthetase from Streptococcus pneumoniae ' [patent_app_type] => B1 [patent_app_number] => 09/492581 [patent_app_country] => US [patent_app_date] => 2000-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12321 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346409.pdf [firstpage_image] =>[orig_patent_app_number] => 09492581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1554235 [patent_doc_number] => 06348585 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-19 [patent_title] => 'Human urotensin II' [patent_app_type] => B1 [patent_app_number] => 09/477071 [patent_app_country] => US [patent_app_date] => 2000-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9590 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/348/06348585.pdf [firstpage_image] =>[orig_patent_app_number] => 09477071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 695841 [patent_doc_number] => 07071316 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-07-04 [patent_title] => 'Human Akt-3' [patent_app_type] => utility [patent_app_number] => 09/869079 [patent_app_country] => US [patent_app_date] => 1999-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 11803 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/071/07071316.pdf [firstpage_image] =>[orig_patent_app_number] => 09869079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6242339 [patent_doc_number] => 20020045249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'DNA ENCODING OVINE ADENOVIRUS (OAV287) AND ITS USE AS A VIRAL VECTOR' [patent_app_type] => new [patent_app_number] => 09/464767 [patent_app_country] => US [patent_app_date] => 1999-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 7554 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045249.pdf [firstpage_image] =>[orig_patent_app_number] => 09464767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 993815 [patent_doc_number] => 06916915 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-07-12 [patent_title] => 'Stressor regulated genes' [patent_app_type] => utility [patent_app_number] => 09/437450 [patent_app_country] => US [patent_app_date] => 1999-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 47 [patent_no_of_words] => 8748 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/916/06916915.pdf [firstpage_image] =>[orig_patent_app_number] => 09437450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1360827 [patent_doc_number] => 06569677 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-27 [patent_title] => 'Modified adenoviral fiber and target adenoviruses' [patent_app_type] => B1 [patent_app_number] => 09/402401 [patent_app_country] => US [patent_app_date] => 1999-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11633 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/569/06569677.pdf [firstpage_image] =>[orig_patent_app_number] => 09402401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4085919 [patent_doc_number] => 06133028 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Defective adenoviruses and corresponding complementation lines' [patent_app_type] => 1 [patent_app_number] => 9/409670 [patent_app_country] => US [patent_app_date] => 1999-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 22474 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133028.pdf [firstpage_image] =>[orig_patent_app_number] => 409670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1541372 [patent_doc_number] => 06372208 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-16 [patent_title] => 'Method of reducing an immune response to a recombinant virus' [patent_app_type] => B1 [patent_app_number] => 09/407490 [patent_app_country] => US [patent_app_date] => 1999-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 17 [patent_no_of_words] => 13734 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/372/06372208.pdf [firstpage_image] =>[orig_patent_app_number] => 09407490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1503080 [patent_doc_number] => 06465211 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-15 [patent_title] => 'Nucleic acids, vectors and transformed cells for making and using high affinity IP-3 binding polypeptides' [patent_app_type] => B1 [patent_app_number] => 09/385222 [patent_app_country] => US [patent_app_date] => 1999-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 22 [patent_no_of_words] => 23346 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/465/06465211.pdf [firstpage_image] =>[orig_patent_app_number] => 09385222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5910771 [patent_doc_number] => 20020144302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'NOVEL CONSTRUCTS AND VECTORS FOR THE TARGETED AND INDUCIBLE EXPRESSION OF GENES' [patent_app_type] => new [patent_app_number] => 09/297910 [patent_app_country] => US [patent_app_date] => 1999-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9459 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20020144302.pdf [firstpage_image] =>[orig_patent_app_number] => 09297910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4300313 [patent_doc_number] => 06251633 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Polynucleotides encoding Staphylococcus aureus FtsA polypeptide' [patent_app_type] => 1 [patent_app_number] => 9/342459 [patent_app_country] => US [patent_app_date] => 1999-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13803 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251633.pdf [firstpage_image] =>[orig_patent_app_number] => 342459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1392115 [patent_doc_number] => 06541244 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-01 [patent_title] => 'Suppressor of cytokine signaling (SOCS)-3 promoter and methods for its use in genetic therapy in humans' [patent_app_type] => B1 [patent_app_number] => 09/327138 [patent_app_country] => US [patent_app_date] => 1999-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 15625 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541244.pdf [firstpage_image] =>[orig_patent_app_number] => 09327138 [rel_patent_id] =>[rel_patent_doc_number] =>)